Bayesian Capital Management’s GE HealthCare GEHC Stock Holding History

Bayesian Capital Management’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,200	Closed	-$262K	–	171
2025 Q4	$262K	Buy	+3,200	New	+$249K	0.6%	66
2025 Q3	–	Sell	-55,606	Closed	-$4.12M	–	630
2025 Q2	$4.12M	Buy	55,606 +52,900	+1,955%	+$3.68M	0.65%	29
2025 Q1	$218K	Sell	2,706 -7,022	-72%	-$603K	0.04%	472
2024 Q4	$761K	Buy	+9,728	New	+$827K	0.09%	291
2024 Q3	–	Sell	-13,700	Closed	-$1.07M	–	810
2024 Q2	$1.07M	Sell	13,700 -76,600	-85%	-$6.25M	0.12%	217
2024 Q1	$8.21M	Buy	+90,300	New	+$7.51M	0.78%	12
2023 Q2	–	Sell	-22,058	Closed	-$1.81M	–	889
2023 Q1	$1.81M	Buy	+22,058	New	+$1.57M	0.22%	123

Other funds holding GEHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bayesian Capital Management's GEHC Position: Q1 2026 in Review

Bayesian Capital Management sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 3,200 shares — an estimated $262K sold.

Bayesian Capital Management first reported a position in GEHC in Q1 2023 and held it in 7 quarters. The position peaked at $8.21M in Q1 2024. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Bayesian Capital Management reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Bayesian Capital Management sold 3,200 GE HealthCare shares in Q1 2026, an estimated $262K.
Bayesian Capital Management first reported a position in GE HealthCare in Q1 2023 and held it in 7 quarters.
Bayesian Capital Management's GE HealthCare position peaked at $8.21M in Q1 2024.
1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.